SEBIO 2012 Board of Directors

Officers:
Chair: Aaron Davidson, H.I.G. BioVentures
Vice-Chair: Becky Kaufman, King & Spalding LLP
Treasurer: Jim Bongiorno, Ernst & Young
Secretary: Becky Kaufman, King & Spalding LLP

Executive Committee:
Jim Bongiorno, Ernst & Young
Todd Brady, Domain Associates
Charlie Craig, Georgia Bio
Aaron Davidson, H.I.G. BioVentures
David Day, University of Florida, Office of Technology Licensing
Tim Gupton, Hughes Pittman & Gupton, LLP
Mike Gutch, MedImmune Ventures
Frank Hunt, bioStrategies, Inc.
Becky Kaufman, King & Spalding LLP
Garheng Kong, Sofinnova Ventures
Jennifer Moore, SEBIO Executive Director
Doug Reed, Hatteras Venture Partners
Rose Ritts, Duke University Office of Licensing & Ventures
Seth Rudnick, Canaan Partners
Ken Tindall, North Carolina Biotechnology Center
Sue Washer, AGTC

Directors:
Brian K. Adams, Arbor Pharmaceuticals, Inc.
Russell Allen, BioFlorida
Greg Anglum, Grant Thornton
Mark Augusti, Smith & Nephew
Michael Bolick, SC BIO
William Brooke, Harbert Venture Partners
Gerry Brunk, Lumira Capital
Tom Callaway, Life Science Partner
Kathy Carr, Tall Oaks Capital
Susan Casey, Square 1 Bank
Nic Chronos, St. Joseph’s Translational Research Institute
Leslie Croland, Edwards, Angell, Palmer & Dodge LLP
W. Mark Crowell, University of Virginia
Steve Hall, Lilly Ventures
Mark Herzog, Virginia Biotechnology Association
Claudia Hillinger, Max Planck Florida Institute
Rick Kent, Intersouth Partners
Ed Mathers, NEA
Tina McKeon, Meunier Carlin & Curfman, LLC
Dan Myers, Alimera Sciences, Inc.
Kathy Nugent, BioAlabama
John Richard, Georgia Venture Partners
Matt Rieke, Quaker Partners
Larry Robbins, Wyrick Robbins Yates & Ponton LLP
Todd Sherer, Emory University Office of Technology Transfer
Susan Shows, Georgia Research Alliance
Philip Street, Kilpatrick Stockton LLP
Samuel Taylor, North Carolina Biosciences Organization
Jan Turek, Biolex Therapeutics
Miriam Wilson, Council for Entrepreneurial Development
Bill Wofford, Hutchison Law Group
Ford Worthy, Pappas Ventures